Peptides for Hair: What the Research Pipeline Actually Looks Like

By BioLabs Research · October 4, 2026 · 5 min read

Hair care has become the next big peptide category. Behind the shampoo ads is a research pipeline that runs from computer models to petri dishes to a few small trials.

Why hair is the next peptide frontier

Skincare made peptides famous, and hair care is catching up. Glossy traces part of the momentum to K-18, a peptide hair-repair brand that launched in 2020 and was sold to Unilever in 2023 for more than $1 billion. The outlet also describes a new wave of peptide launches in 2026 (Glossy).

"Peptides for hair" can mean two very different things, though, and the difference matters:

1. Peptides that work on the hair fiber, the strand you can see. The goal here is strength, smoothness and less breakage. 2. Peptides studied around the hair follicle, the living structure under the scalp. This research is about how follicles grow and cycle.

The first is cosmetic territory. The second gets close to what US law treats as a drug claim. FDA lists claims that a product will "restore hair growth" as an example of a claim that can make a product a drug (FDA: Is It a Cosmetic, a Drug, or Both?). Keep that line in mind as you read hair-peptide marketing.

Track 1: Strengthening the fiber, and the AI-designed peptide

The most futuristic story in hair peptides right now comes from Korean beauty company Amorepacific.

According to the company, its R&I Center used AI-assisted molecular docking and molecular-dynamics simulations to screen about 8,000 candidate compounds for ones that bind strongly to hair keratin, the protein that makes up most of the hair shaft. The top candidate was a three-amino-acid peptide called Tripeptide-132 (sequence KCV) (Amorepacific, March 2026).

The peer-reviewed paper in the International Journal of Cosmetic Science reports that, in lab tests on hair fibers:

• A modified (palmitoylated) form increased tensile strength by up to 44% compared with untreated controls.
• Treatment reduced mechanical breakage by roughly 48% to 52%.
• Confocal microscopy showed the peptide penetrating into the cuticle and cortex of the hair strand.

(Rha et al., International Journal of Cosmetic Science, "Bio-active designed peptide for hair keratin strengthening")

How to read this: these are measurements on hair fibers in a lab, not on people's heads. They tell us about strand mechanics, not hair growth. The research was done by the company that sells products using the peptide. The approach is new and interesting: computational design first, lab validation second. Independent replication would strengthen it.

Track 2: Copper peptides and the follicle

Copper peptides, best known from skincare, are also the most-cited peptides in follicle research.

Reviews by GHK-Cu discoverer Loren Pickart and colleagues list increased hair follicle size among the effects reported for GHK-Cu in research models (Pickart, 2008; Pickart & Margolina, 2018). As with the skin research, much of this literature comes from a small group of authors, listed at a skincare company's R&D address, so independent confirmation is valuable.

A 2007 study from Seoul National University's dermatology department is sometimes lumped in with GHK-Cu research, but it tested a related copper complex, AHK-Cu. The researchers reported that AHK-Cu lengthened human hair follicles kept alive in culture (ex vivo) and increased the growth of dermal papilla cells, which help control follicle growth (Pyo et al., Archives of Pharmacal Research, 2007). That is a meaningful lab result. It is not a clinical trial, and it is not GHK-Cu.

Track 3: Signal peptides and botanical combinations

Some cosmetic ingredient suppliers have tested peptide-plus-botanical combinations on the scalp. One example is a randomized, placebo-controlled study of 30 volunteers using a cosmetic active that combines a red clover (Trifolium pratense) flower extract with a "biomimetic peptide." The authors, from the ingredient supplier's R&D department, reported shifts in the ratio of growing to resting hairs after four months, measured with TrichoScan imaging (Loing et al., Journal of Cosmetic Science, 2013).

How to read this: 30 people, one study, run by the company that makes the ingredient. It's a signal worth noting, not a settled conclusion.

Track 4: Larger peptides in animal research

Further from the beauty aisle, some larger signaling peptides have been studied in animal hair models. A 2004 study from the US National Institutes of Health reported that thymosin beta-4, a 43-amino-acid peptide, stimulated hair growth in rats and mice and affected the migration of follicle stem cells (Philp et al., The FASEB Journal, 2004).

This is basic research in rodents. It explains why the molecule interests biologists. It does not show anything about human use.

Cosmetic claims vs. research findings: a quick decoder

| What the label says | What the research behind it usually is | |---|---| | "Strengthens," "reduces breakage" | Lab tests on hair fibers (tensile strength, combing) | | "Supports a healthy-looking scalp" | Often small cosmetic trials, frequently sponsored by suppliers | | "Copper peptide" | Ingredient with cell, tissue and animal research, plus small topical trials | | Anything implying it "regrows" hair | Under FDA's framework, a claim like this can make a product a drug (FDA) |

What we know / What we don't know

What we know

• Peptides designed to bind keratin can measurably change hair-fiber mechanics in lab tests (Rha et al.).
• Copper-peptide complexes have shown effects on cultured human follicles and follicle cells (Pyo et al., 2007).
• Some peptides affect hair cycling in rodent models (Philp et al., 2004).

What we don't know

• How lab results on follicles and fibers translate to finished products used on real scalps.
• Results from large, independent, long-term trials for most hair peptides. Much of the existing research is small and industry-run.

These are research findings, not promises about any product. Research materials are not drugs or supplements.

Related reading: Today's peptide headlines on /hot

---

Sources are linked inline. This article summarizes published research for general information. It is not medical advice. BioLabs Research supplies research materials, not drugs or supplements, for laboratory research use only.

For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.

This summary is for research-community awareness only and is not legal advice.